Scholars Central

Conference abstractPublished 8 May 2017

Hydroxyurea, an effective therapy to avoid splenectomy in sickle cell disease and thalassemia: Single institute experience in Saudi Arabia

Authors: Soad K Al Jaouni

King Abdulaziz University, KSA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background & Aim: Spleen plays an important part in the immune system which helps the body to fight against infection and has a major role in children. Splenectomy has been decline in hemoglobin disorders in recent years. Aim of this study is to assess the role of hydroxyurea and to eliminate the risk of splenectomy in sickle cell disease (SCD) and thalassemia at our medical center. Methods: Total of 54 patients enrolled in the study from 2004 to 2016 at King Abdulaziz University Hospital, Faculty of Medicine and King Abdulaziz University, Saudi Arabia. 25 sickle cell disease (SCD), 17 thalassemia major (TM) were suboptimal transfusion dependents and hypersplenism, 12 thalassemia inter media (TI). Results: Risk of splenectomy has been avoided in 24/25 SCD, 15/17 in TM and 12/12 in TI. Conclusion: Hydroxyurea is an effective and safe therapy can eliminate risk of splenectomy in SCD and thalassemia. Recent studies and meta-analysis showed that hydroxyurea is safe and non-carcinogenic.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • BylineArticles whose byline prints “Soad K Al Jaouni”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels